Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 27, 2015 9:52 AM ET

Biotechnology

Company Overview of Syndax Pharmaceuticals, Inc.

Key Executives for Syndax Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Arlene M. Morris 128 RelationshipsChief Executive Officer, President and Director62
Michael Downes Ph.D.No RelationshipsCo-Founder--
Ronald M. Evans Ph.D.42 RelationshipsCo-Founder and Advisor--
Richard A. Heyman Ph.D.78 RelationshipsCo-Founder57
Peter Ordentlich Ph.D.No RelationshipsCo-Founder and Chief Technology Officer45
View More Key Executives

Syndax Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Dennis G. Podlesak MBA 43 RelationshipsCalixa Therapeutics, Inc.56
Arlene M. Morris 128 RelationshipsSyndax Pharmaceuticals, Inc.62
Kim Puloma Kamdar Ph.D. 95 RelationshipsDomain Associates, L.L.C.46
Luke B. Evnin Ph.D. 106 RelationshipsMPM Capital51
Richard P. Shea 7 RelationshipsMomenta Pharmaceuticals Inc.62
View All Board Members

Syndax Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Richard P. Shea7 Relationships3 Executives
Compensation Committee Ph.D.Luke B. Evnin106 Relationships3 Executives
Nominating Committee Ph.D.Kim Puloma Kamdar95 Relationships3 Executives
Corporate Governance Committee Ph.D.Kim Puloma Kamdar95 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$409.5K
409.5K
367.6K
Bonus$178.0K
178.0K
244.1K
Total Short Term Compensation
Not meaningful
Total Value of Options$587.5K
587.5K
35.9M
Compensation as of Fiscal Year 2013
Syndax Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Anders Nyrén to Leave His Assignment as Member of SCA Board of Directors as of April 30, 2015
April 27, 2015 5:58 AM ET
The Clorox Company Announces Retirement of Daniel Boggan as Directors, Effective May 13, 2015
April 24, 2015 9:00 PM ET
Worldwise Promotes Jeff Leh to Vice President of Sales
April 22, 2015 10:15 AM ET
Oil-Dri Corp. of America Announces Management Changes
April 17, 2015 8:15 PM ET
P&G Announces Executive Changes
April 14, 2015 1:58 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Syndax Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.